JournalTOCs

Expert Opinion on Emerging Drugs
Journal Prestige (SJR): 1.109

Citation Impact (citeScore): 3
Number of Followers: 7

Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1472-8214 - ISSN (Online) 1744-7623
Published by Taylor and Francis

[2652 journals]

Correction
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Pages: i - i
  Abstract: Volume 29, Issue 2, June 2024, Page i-i
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-18T10:12:42Z
  DOI: 10.1080/14728214.2024.2342646
  Issue No: Vol. 29, No. 2 (2024)
Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Simone Di Cola Saniya Khan Lucia Lapenna Manuela Merli Department of Translational; Precision Medicine, Sapienza University of Rome, Rome, Italy
  Pages: 81 - 91
  Abstract: Volume 29, Issue 2, June 2024, Page 81-91
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-03-29T05:19:07Z
  DOI: 10.1080/14728214.2024.2332428
  Issue No: Vol. 29, No. 2 (2024)
Evaluating emerging drugs in phase II & III for the treatment of
amyotrophic lateral sclerosis
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Xiaoyan Li Richard Bedlack Department of Neurology; Duke University, Durham, NC, USA
  Pages: 93 - 102
  Abstract: Volume 29, Issue 2, June 2024, Page 93-102
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-03-22T12:20:45Z
  DOI: 10.1080/14728214.2024.2333420
  Issue No: Vol. 29, No. 2 (2024)
An extract of phase II and III trials on recent developments in managing
neuropathic pain syndromes: diabetic peripheral neuropathy, trigeminal
neuralgia, and postherpetic neuralgia
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: William C. Upshaw Lenise G. Soileau Nicholas R. Storey Kassady A. Perkinson Patrick M. Luther Noah J. Spillers Christopher L. Robinson Benjamin C. Miller Shahab Ahmadzadeh Omar Viswanath Sahar Shekoohi Alan D. Kaye a School of Medicine; Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, USAb Edward Via College of Osteopathic Medicine, Monroe, LA, USAc Beth Israel Deaconess Medical Center, Department of Anesthesiology, Critical Care, Pain Medicine, Harvard Medical School, Boston, MA, USAd Department of Anesthesiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USAe Creighton University School of Medicine, Phoenix, AZ, USA
  Pages: 103 - 112
  Abstract: Volume 29, Issue 2, June 2024, Page 103-112
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-03-01T06:51:21Z
  DOI: 10.1080/14728214.2024.2323193
  Issue No: Vol. 29, No. 2 (2024)
Emerging drugs for the treatment of herpetic keratitis
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Divya Kapoor Pankaj Sharma Deepak Shukla a Department of Microbiology; Visual Sciences, University of Illinois Medical Center, Chicago, IL, USA
  Pages: 113 - 126
  Abstract: Volume 29, Issue 2, June 2024, Page 113-126
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-11T05:46:03Z
  DOI: 10.1080/14728214.2024.2339899
  Issue No: Vol. 29, No. 2 (2024)
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic
steatohepatitis
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Michihiro Iwaki Masato Yoneda Naohiro Wada Tomohiro Otani Takashi Kobayashi Asako Nogami Satoru Saito Atsushi Nakajima a Department of Gastroenterology; Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japanb Department of Gastroenterology, Sanno Hospital, Minato-Ku, Tokyo, Japan
  Pages: 127 - 137
  Abstract: Volume 29, Issue 2, June 2024, Page 127-137
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-03-25T08:21:45Z
  DOI: 10.1080/14728214.2024.2328036
  Issue No: Vol. 29, No. 2 (2024)
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Valentina Favorito Ilaria Ricciotti Andrea De Giglio Laura Fabbri Renata Seminerio Alessandro Di Federico Eleonora Gariazzo Silvia Costabile Giulio Metro a Department of Medical; Surgical Sciences, University of Bologna, Bologna, Italyb Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italyc Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy
  Pages: 139 - 154
  Abstract: Volume 29, Issue 2, June 2024, Page 139-154
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-09T05:56:54Z
  DOI: 10.1080/14728214.2024.2331139
  Issue No: Vol. 29, No. 2 (2024)
Evolving role of VIADISC for chronic low back and discogenic pain: a
narrative review
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Jack K. Tolson Robert L. Menuet Gianni H. Ly Benjamin A. Chanes Elizabeth A. Bryan Saurabh Kataria Julian Kim Shahab Ahmadzadeh Sahar Shekoohi Alan D. Kaye a School of Medicine; Louisiana State University Health Science Center Shreveport, Shreveport, LA, USAb Department of Neurology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, USAc Department of Anesthesiology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, USAd Departments of Anesthesiology Neurosciences, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, USA
  Pages: 155 - 164
  Abstract: Volume 29, Issue 2, June 2024, Page 155-164
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-15T01:04:16Z
  DOI: 10.1080/14728214.2024.2339912
  Issue No: Vol. 29, No. 2 (2024)
Emerging monoclonal antibody therapy for head and neck squamous cell
carcinoma
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Francis Proulx-Rocray Denis Soulières Hematology; Medical Oncology Department, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC, Canada
  Pages: 165 - 176
  Abstract: Volume 29, Issue 2, June 2024, Page 165-176
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-15T07:22:23Z
  DOI: 10.1080/14728214.2024.2339906
  Issue No: Vol. 29, No. 2 (2024)
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in
phase II & III clinical trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sarah MacIsaac Dujrath Somboonviboon Ciaran Scallan Martin Kolb a Firestone Institute for Respiratory Health – Division of Respirology; McMaster University, St. Joseph’s Healthcare Hamilton, Hamilton, ON, Canadab Division of Respirology, Dalhousie University, Halifax Infirmary, Halifax Nova Scotia, Canadac Division of Pulmonary Critical Care, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand
  Pages: 177 - 186
  Abstract: Volume 29, Issue 2, June 2024, Page 177-186
  .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-11T05:42:06Z
  DOI: 10.1080/14728214.2024.2340723
  Issue No: Vol. 29, No. 2 (2024)
A comprehensive review of phase 2/3 trials in osteoarthritis: an expert
opinion
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Liyang Pan Lydia Nagib Sujata Ganguly Arumugam Moorthy Hasan Tahir a General internal medicine; Imperial College Healthcare NHS Trust, London, UKb General internal medicine, Royal Free London NHS Foundation Trust, London, UKc Department of rheumatology, University Hospitals of Leicester NHS Trust, Leicester, UKd Department of rheumatology, University College London, London, UK
  Pages: 1 - 13
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-08-05T10:57:42Z
  DOI: 10.1080/14728214.2024.2386174
Current and emerging drug treatment strategies to tackle sickle cell
anemia
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yogindra Persaud Alexis Leonard Parul Rai Department of Hematology; St. Jude Children’s Research Hospital, Memphis, TN, USA
  Pages: 1 - 20
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-07-22T12:43:56Z
  DOI: 10.1080/14728214.2024.2379260
Emerging drugs for the treatment of progressive familial intrahepatic
cholestasis: a focus on phase II and III trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Willemien F.J. Hof Jan Freark de Boer Henkjan J. Verkade a Department of Pediatrics; University Medical Center Groningen, Groningen, The Netherlandsb Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands
  Pages: 1 - 16
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-07-05T06:54:27Z
  DOI: 10.1080/14728214.2024.2336986
Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023
update
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Joshua Winograd Nikit Venishetty Alia Codelia-Anjum Naeem Bhojani Dean Elterman Kevin C. Zorn Alexis Te Bilal Chughtai a Department of Urology; Weill Cornell Medicine, New York, NY, USAb Paul L. Foster School of Medicine, Texas Tech Health Sciences Center, El Paso, TX, USAc Division of Urology, University of Montreal, Montreal, Québec, Canadad Division of Urology, University of Toronto, Toronto, Ontario, Canada
  Pages: 1 - 13
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-06-14T09:55:08Z
  DOI: 10.1080/14728214.2024.2363213
Emerging therapies for treatment of agitation, psychosis, or apathy in
Alzheimer’s disease
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Hui Jue Wang Arun Chinna-Meyyappan Oriel J. Feldman Krista L. Lanctôt a Neuropsychopharmacology Group; Sunnybrook Research Institute, Toronto, ON, Canadab Department of Pharmacology Toxicology, University of Toronto, Toronto, ON, Canadac Department of Psychiatry, University of Toronto, Toronto, ON, Canadad Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-06-11T12:17:52Z
  DOI: 10.1080/14728214.2024.2363215
Emerging drugs for the treatment of short bowel syndrome
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Tristan Frau Myriam El Khatib Brune De Dreuille Lore Billiauws Alexandre Nuzzo Francisca Joly a Hopital Beaujon - Department of Gastroenterology; Metabolic Dysfunctions in Nutritional Pathologies, Inserm UMR 1149, Centre de Recherche sur l’Inflammation Paris Montmartre, UFR de Médecine Paris Diderot Paris, Francec Hôpital Bichat, Laboratory for Vascular Translational Science, Paris, France
  Pages: 1 - 12
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-05-23T03:00:47Z
  DOI: 10.1080/14728214.2024.2357567
Aticaprant: (a κ-opioid receptor antagonist) for major depressive
disorder
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Elliot Hampsey Luke Jelen Allan H. Young a Centre for Affective Disorders; King’s College London, London, UKb South London & Maudsley NHS Foundation Trust, London, UK
  Pages: 1 - 12
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-05-08T02:28:35Z
  DOI: 10.1080/14728214.2024.2345645
Emerging immunotherapies in the Hodgkin lymphoma armamentarium
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Michael A. Spinner Ranjana H. Advani a Division of Hematology/Oncology; Department of Medicine, University of California, San Francisco, CA, USAb Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA
  Pages: 1 - 13
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-05-07T06:19:09Z
  DOI: 10.1080/14728214.2024.2349083
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2
and phase 3 trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Ogechi Obed Albert C. Chong Malcolm Su Peck Y. Ong a Keck School of Medicine; University of Southern California, Los Angeles, CA, USAb Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USAc Division of Clinical Immunology Allergy, Children’s Hospital Los Angeles; Department of Pediatrics, University of Southern California, Los Angeles, CA, USA
  Pages: 1 - 17
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-29T05:23:59Z
  DOI: 10.1080/14728214.2024.2345643
Emerging and traditional 5-α reductase inhibitors and androgen receptor
antagonists for male androgenetic alopecia
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Aditya K. Gupta Mesbah Talukder Greg Williams a Mediprobe Research Inc; London, ON, Canadab Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canadac School of Pharmacy, BRAC University, Dhaka, Bangladeshd Farjo Hair Institute, London, UK
  Pages: 1 - 11
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-26T12:13:48Z
  DOI: 10.1080/14728214.2024.2346590
Emerging drugs in phase II and III clinical development for the treatment
of alcohol use disorder
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sophie Köhne Thomas Hillemacher Alexander Glahn Patrick Bach a Department of Psychiatry; Social Psychiatry Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim. Heidelberg University, Heidelberg, Germanyd Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
  Pages: 1 - 14
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-18T11:48:48Z
  DOI: 10.1080/14728214.2024.2342951
Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024
update
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Jonathan A. Fallowfield Maria Jimenez Ramos Centre for Inflammation Research; Institute for Regeneration Repair, University of Edinburgh, Edinburgh, UK
  Pages: 1 - 6
  Abstract: .
  
  Citation: Expert Opinion on Emerging Drugs
  PubDate: 2024-04-16T05:33:56Z
  DOI: 10.1080/14728214.2024.2341878

HOME > Browse the 73 Subjects covered by JournalTOCs
Subject	Total Journals